What You Should Know:

您应该知道：

– Salesforce announced the general availability of Life Sciences Cloud, a platform for pharmaceutical (pharma) and medical technology (medtech) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline clinical operations with data, automation, and trusted AI..

–Salesforce宣布全面推出生命科学云，这是一个面向制药（pharma）和医疗技术（medtech）组织的平台，可帮助个性化患者和医疗保健专业人员（HCP）的参与，并通过数据、自动化和可信的人工智能简化临床操作。。

– By harnessing the power of AI and automation, it empowers pharma and medtech companies to streamline operations, improve patient care, and ultimately accelerate the development of life-saving treatments.

–通过利用人工智能和自动化的力量，它使制药和医疗技术公司能够简化运营，改善患者护理，并最终加速救生治疗的发展。

The Challenge: Time-Consuming Trials and Patient Drop-Off

挑战：耗时的试验和患者流失

Recruiting participants for clinical trials is a notoriously cumbersome process, often taking up to one-third of a study’s duration. Shockingly, 80% of trials fail to enroll enough patients, leading to delays and inflated costs. Even after a drug reaches the market, patient adherence remains a significant hurdle.

招募参与者进行临床试验是一个众所周知的麻烦过程，通常会占用研究时间的三分之一。令人震惊的是，80%的试验未能招募足够的患者，导致延误和成本膨胀。即使在药物上市后，患者依从性仍然是一个重大障碍。

Studies reveal that nearly 40% of patients abandon their medication within the first year. Life Sciences Cloud tackles these challenges head-on, empowering pharma and medtech companies to improve efficiency, enhance patient support, and strengthen relationships with healthcare professionals (HCPs)..

研究表明，近40%的患者在第一年内放弃了药物治疗。生命科学云正面应对这些挑战，使制药和医疗技术公司能够提高效率，增强患者支持，并加强与医疗保健专业人员（HCP）的关系。。

Innovation at its Finest: AI Streamlines Processes

最佳创新：AI简化流程

Life Sciences Cloud leverages the robust Einstein 1 Platform to deliver an end-to-end, AI-powered solution. Here are some of the key features designed to improve patient recruitment, clinical trial management, and patient care:

。以下是一些旨在改进患者招募、临床试验管理和患者护理的关键功能：

Participant Recruitment & Enrollment: This feature empowers Contract Research Organizations (CROs), clinical trial sites, and sponsors to identify qualified and diverse candidates. Utilizing generative AI, research coordinators can match patients to appropriate trials based on eligibility criteria, significantly reducing manual screening and saving precious time.

参与者招募和注册：此功能使合同研究组织（CRO），临床试验地点和赞助商能够识别合格且多样化的候选人。利用生成性人工智能，研究协调员可以根据资格标准将患者匹配到适当的试验中，从而大大减少了手动筛查并节省了宝贵的时间。

Additionally, patient portals simplify trial discovery for eligible individuals, allowing them to express interest in relevant studies.Patient Benefits Verification: Life Sciences Cloud simplifies the often-complex process of determining out-of-pocket costs and financial assistance options for patients.

此外，患者门户简化了符合条件的个体的试验发现，使他们能够表达对相关研究的兴趣。患者利益验证：生命科学云简化了确定患者自付费用和财务援助选项的复杂过程。

Features include insurance coverage analysis, proactive alerts for expiring service level agreements (SLAs), and a centralized dashboard for easy access to patient benefit information. This empowers patient service agents to generate benefits summaries and streamline re-verification processes, ensuring continuity of care for patients.Patient Program Outcome Management: This feature assists patient service teams in capturing and analyzing the impact of educational and support programs.

其功能包括保险范围分析、针对过期服务级别协议（SLA）的主动警报，以及便于访问患者福利信息的集中式仪表板。这使患者服务代理能够生成福利摘要并简化重新验证流程，从而确保患者护理的连续性。患者计划结果管理：此功能可帮助患者服务团队捕获和分析教育和支持计划的影响。

By tracking patient milestones and generating reports on program effectiveness, healthcare providers can identify successful engagement tactics and tailor programs to improve medication adherence and reduce treatment drop-off rates..

通过跟踪患者里程碑并生成有关计划有效性的报告，医疗保健提供者可以确定成功的参与策略，并定制计划，以提高药物依从性并降低治疗辍学率。。

Enhanced HCP Engagement & Unified Data Platform

增强HCP参与度和统一数据平台

Life Sciences Cloud for Customer Engagement streamlines interactions with HCPs, providing a holistic view for marketing, sales, and medical science liaison teams. This eliminates redundant outreach and ensures compliance through comprehensive audit trails. Real-time insights, analytics, and past interaction history are readily available within workflows, empowering onsite sales representatives to deliver dynamic presentations and track engagement metrics directly from their mobile devices..

用于客户参与的生命科学云简化了与HCP的交互，为营销、销售和医学科学联络团队提供了整体视图。这消除了多余的外联，并通过全面的审计跟踪确保了法规遵从性。实时见解、分析和过去的交互历史在工作流中随时可用，使现场销售代表能够直接从其移动设备提供动态演示和跟踪参与度指标。。

Furthermore, the Unified Data Platform, built on Salesforce Data Cloud and MuleSoft for Life Sciences, offers a complete and harmonized view of each patient and HCP. Data from various sources like emails, reports, and scientific publications is integrated into a unified data model. This allows for building comprehensive patient profiles, personalizing interactions, and fostering stronger connections between HCPs and patients.

此外，基于Salesforce Data Cloud和MuleSoft for Life Sciences构建的统一数据平台为每位患者和HCP提供了完整而协调的视图。来自电子邮件、报告和科学出版物等各种来源的数据被集成到统一的数据模型中。这可以建立全面的患者档案，个性化互动，并在HCP和患者之间建立更强的联系。

Additionally, Salesforce’s open ecosystem allows for seamless integration of third-party data, enabling personalized content delivery to HCPs..

此外，Salesforce的开放生态系统允许无缝集成第三方数据，从而实现向HCP的个性化内容交付。。

Availability

可用性

Life Sciences Cloud offers a phased rollout:

生命科学云分阶段推出：

Now Available: Participant Recruitment and Enrollment features with screening, e-consent, and simple randomization. Pharmacy Benefits Verification. Unified Data Platform.Late 2024: AI enhancements for patient recruitment matching.October 2024: Patient Program Outcome Management.September 2025: Life Sciences Cloud for Customer Engagement..

现在可用：参与者招募和注册功能，包括筛选，电子同意和简单随机化。药房福利验证。统一数据平台。2024年末：患者招募匹配的AI增强。2024年10月：患者计划结果管理。2025年9月：生命科学云用于客户参与。。

“With a backdrop of rising drug costs, frustrated doctors, confused patients, and regulatory scrutiny, life sciences organizations must find ways to do more with less. AI opens the door for pharma and medtech organizations to reimagine their operations while promoting a focus on patients. With these new innovations from Salesforce, life sciences organizations can access the power of predictive and generative AI to make the best use of their data quickly, while helping to automate administrative tasks and identify potential risks in real time.” – Frank Defesche, Senior Vice President and General Manager for Life Sciences..

“在药品成本上涨、医生沮丧、患者困惑和监管审查的背景下，生命科学组织必须找到用更少的钱做更多事情的方法。人工智能为制药和医学技术组织打开了大门，让它们重新思考自己的运营，同时促进对患者的关注。有了Salesforce的这些新创新，生命科学组织可以利用预测性和生成性人工智能的力量，快速充分利用其数据，同时帮助自动化管理任务并实时识别潜在风险。”——生命科学高级副总裁兼总经理弗兰克·德菲舍斯。。